Research study Program year 2023 Source: CMS Open Payments

Aflibercept 8mg in RVO

Research payments

$1,448,470

799 payments

Through program year 2023, $1,448,470 in research payments was reported against Aflibercept 8mg in RVO, across 799 payments, paid by Bayer HealthCare Pharmaceuticals Inc..

Paid by
Bayer HealthCare Pharmaceuticals Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

1 row
Year Kind Amount Payments
2023 Research $1,448,470 799

Breakdown

Who paid Research payments · program year 2023
  1. Bayer HealthCare Pharmaceuticals Inc. $1,448,470 799 payments
Who received the money Research payments · program year 2023
  1. Retina Consultants Of Texas Organisation paid for research $237,630 164 payments
  2. Cumberland Valley Retina Consultants Organisation paid for research $232,917 59 payments
  3. Long Island And Queens Vitreoretinal Consultants PC Organisation paid for research $94,322 49 payments
  4. Total Practice Management Organisation paid for research $88,940 84 payments
  5. Vitreoretinal Surgery PA Organisation paid for research $84,396 43 payments
  6. Rand Eye Institute Organisation paid for research $73,671 46 payments
  7. Palmetto Retina Center LLC Admin Office Organisation paid for research $65,533 27 payments
  8. Retina Associates Organisation paid for research $65,443 55 payments
  9. Austin Retina Associates Organisation paid for research $63,767 19 payments
  10. Texas Retina Associates Organisation paid for research $61,909 38 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record